PegBio Co (HKSE:02565) ROE % Adjusted to Book Value: -1.20% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02565 PegBio Co Ltd HKSE:02565
11 GF Score
Price HK$6.58
! 4 Warning Signs
View Full Analysis

What is PegBio Co ROE % Adjusted to Book Value?

PegBio Co HKSE:02565 +23.59% 11 ROE % Adjusted to Book Value is -1.20% as of Dec. 2025. GuruFocus rates HKSE:02565 with a GF Score™ of 11/100. The stock has 4 warning signs investors should review.

PegBio Co's ROE % for the quarter that ended in Dec. 2025 was -65.47%. PegBio Co's PB Ratio for the quarter that ended in Dec. 2025 was 54.42. PegBio Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was -1.20%.

PegBio Co ROE % Adjusted to Book Value Related Terms

PegBio Co ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for PegBio Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PegBio Co ROE % Adjusted to Book Value Chart

PegBio Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
0.00 0.00 0.00 -1.53

PegBio Co Semi-Annual Data
Dec22 Dec23 Jun24 Dec24 Jun25 Dec25
ROE % Adjusted to Book Value Get a 7-Day Free Trial 0.00 0.00 0.00 -8.84 -1.20

HKSE:02565 vs VRTX, REGN, RVMD: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, PegBio Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PegBio Co ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PegBio Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where PegBio Co's ROE % Adjusted to Book Value falls into.


HKSE:02565
11GF Score
PegBio Co Ltd HKSE:02565
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PegBio Co ROE % Adjusted to Book Value Calculation

PegBio Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-83.52% / 54.42
=-1.53%

PegBio Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-65.47% / 54.42
=-1.20%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -1.20% mean?
PegBio Co (HKSE:02565) has a ROE % Adjusted to Book Value of -1.20% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on PegBio Co and its competitors.
Is PegBio Co's ROE % Adjusted to Book Value too high?
PegBio Co's current ROE % Adjusted to Book Value is -1.20%. Overall, PegBio Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does PegBio Co's ROE % Adjusted to Book Value compare to VRTX and REGN?
PegBio Co's ROE % Adjusted to Book Value of -1.20% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Biotechnology company?
A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on PegBio Co and its competitors. PegBio Co's current ROE % Adjusted to Book Value is -1.20%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PegBio Co stock overvalued right now?
PegBio Co (HKSE:02565) has a current ROE % Adjusted to Book Value of -1.20%. The current ROE % Adjusted to Book Value is -1.20%. PegBio Co's overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For PegBio Co (HKSE:02565), the current ROE % Adjusted to Book Value is -1.20% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PegBio Co Business Description

Address Haozhang Mansion, Suite 606, Building 1, Gongshu District, Zhejiang, Hangzhou, CHN, 200331
PegBio Co Ltd is engaged in the discovery and development of therapies. The company's main product PB-119, is a self-developed, obtained marketing approval from the National Medical Products Administration (NMPA) and entered commercialization preparation stage, long-acting glucagonlike peptide 1 (GLP-1, a peptide hormone that decreases blood sugar levels) receptor agonist. The Company's product candidates include PB-718, PB-1902, PB-722, PB-2301 and PB-2309.
11GF Score

Get the complete analysis for HKSE:02565

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$6.58
Price